KEAP1 and depressive disorder: Once Nrf2 is activated, Keap1 is released from Nrf2 and promotes nuclear translocation of Nrf2, activating the downstream target proteins HO-1, SOD1, GCLC, and GCLM, thus playing a key role in anti-inflammatory and anti-oxidative stress activities of depression.